PAK4 and triple-negative breast carcinoma: In addition to SUM159 cells, KPT-9274 also reduced PAK4 protein in two other triple negative breast cancer cell lines; MDA-MB-231 and MDA-MB-468 cells, which was most noticeable after 48–72 hours of treatment (Fig. 2D).